Resurgent Financial Advisors’s Clorox CLX Stock Holding History

Resurgent Financial Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,117	Closed	-$157K	–	510
2022 Q4	$157K	Buy	+1,117	New	+$159K	0.08%	235

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Resurgent Financial Advisors's CLX Position: Q1 2023 in Review

Resurgent Financial Advisors sold out of Clorox (CLX) in Q1 2023, closing a stake of 1,117 shares — an estimated $157K sold.

Resurgent Financial Advisors first reported a position in CLX in Q4 2022 and held it in 1 quarter. The position peaked at $157K in Q4 2022. 1,139 funds tracked by Wall St. Rank hold CLX as of Q1 2023.

Resurgent Financial Advisors reported no remaining Clorox position as of Q1 2023 after selling out during the quarter.
Resurgent Financial Advisors sold 1,117 Clorox shares in Q1 2023, an estimated $157K.
Resurgent Financial Advisors first reported a position in Clorox in Q4 2022 and held it in 1 quarter.
Resurgent Financial Advisors's Clorox position peaked at $157K in Q4 2022.
1,139 funds tracked by Wall St. Rank held Clorox as of Q1 2023.

Based on Resurgent Financial Advisors's 13F filing for Q1 2023, filed 15 May 2023.